000 | 01678 a2200493 4500 | ||
---|---|---|---|
005 | 20250513064716.0 | ||
264 | 0 | _c19940708 | |
008 | 199407s 0 0 eng d | ||
022 | _a0268-3369 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGalimberti, M | |
245 | 0 | 0 |
_aAllogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide. _h[electronic resource] |
260 |
_bBone marrow transplantation _cFeb 1994 |
||
300 |
_a197-201 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBone Marrow Transplantation _xadverse effects |
650 | 0 | 4 |
_aBusulfan _xtherapeutic use |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
650 | 0 | 4 |
_aCyclosporine _xtherapeutic use |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGraft vs Host Disease _xprevention & control |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPrednisolone _xtherapeutic use |
650 | 0 | 4 | _aTransplantation, Homologous |
700 | 1 | _aPolchi, P | |
700 | 1 | _aLucarelli, G | |
700 | 1 | _aAngelucci, E | |
700 | 1 | _aBaronciani, D | |
700 | 1 | _aGiardini, C | |
700 | 1 | _aGaziev, D | |
700 | 1 | _aErer, B | |
700 | 1 | _aRipalti, M | |
700 | 1 | _aRapa, S | |
773 | 0 |
_tBone marrow transplantation _gvol. 13 _gno. 2 _gp. 197-201 |
|
999 |
_c8204395 _d8204395 |